| GBP millions | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | Trend | YoY |
|---|---|---|---|---|---|---|---|
| Revenue | 3.4 | 2.0 | 2.0 | 3.8 | 0.0 | −100.0% | |
| Cost of revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Gross profit | 3.4 | 2.0 | 2.0 | 3.8 | 0.0 | −100.0% | |
| Research & development | 8.6 | 6.7 | 6.2 | 7.6 | 7.8 | +2.4% | |
| Selling, general & administrative | 3.0 | 2.2 | 3.1 | 8.7 | 6.9 | −21.4% | |
| Selling & marketing | 0.0 | 0.0 | 0.0 | 0.4 | 0.4 | +0.0% | |
| Operating expenses | 10.1 | 8.3 | 13.5 | 0.1 | 6.9 | +5434.5% | |
| Operating income | (6.6) | (6.9) | (7.3) | (12.1) | (14.2) | −17.8% | |
| Interest expense | 0.3 | 0.3 | 3.4 | 6.8 | 0.0 | −100.0% | |
| Interest income | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | +3660.2% | |
| Other income / expense | (0.3) | (0.3) | (7.7) | 9.1 | 7.2 | −20.0% | |
| Pre-tax income | (6.9) | (6.6) | (15.0) | (3.0) | (7.0) | −130.6% | |
| Income tax | (0.8) | (1.2) | (1.4) | (1.7) | (1.1) | +36.7% | |
| Net income | (6.1) | (5.5) | (13.6) | (1.3) | (5.9) | −349.7% | |
| Discontinued operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Other net income adjustments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| EPS, basic (per share) | (2,150.00) | (1,832.00) | 0.00 | (384.00) | (188.09) | +51.0% | |
| EPS, diluted (per share) | (2,150.00) | (1,832.00) | 0.00 | (384.00) | (188.09) | +51.0% | |
| EBITDA | (5.9) | (5.3) | (10.7) | 4.5 | (13.6) | −403.6% | |
| Depreciation & amortization | 0.7 | 0.9 | 0.8 | 0.8 | 0.6 | −17.4% | |
| Weighted average shares (shares) | 2,805 | 2,805 | 0 | 3,435 | 30,892 | +799.3% | |
| Weighted average diluted shares (shares) | 2,805 | 2,805 | 0 | 3,435 | 30,892 | +799.3% | |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | — | — | |
| Operating margin | −193.8% | −348.1% | −368.3% | −314.3% | — | — | |
| Net margin | −177.1% | −275.8% | −686.1% | −34.2% | — | — |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
Statements are reported in GBP; the shares trade in USD.
